What is Remedy Plan?
Remedy Plan Therapeutics is a pioneering small molecule therapeutics start-up focused on transforming the field of NAMPT inhibition. The company has developed a groundbreaking, tunable mechanism of action for NAMPT inhibition that circumvents severe on-target toxicity, thereby unlocking opportunities to treat a range of diseases driven by NAMPT dysregulation. Their robust pipeline targets solid tumors, hematologic malignancies, obesity, and autoimmune disorders, positioning them at the forefront of innovative pharmaceutical development.
How much funding has Remedy Plan raised?
Remedy Plan has raised a total of $18M across 1 funding round:
Other Financing Round
$18M
Other Financing Round (2025): $18M with participation from Schooner Capital and Alexandria Venture Investments LLC Alexandria Venture Investments
Key Investors in Remedy Plan
Schooner Capital
Schooner Capital, established in 1971, is an investment firm that focuses on sharing visions and fostering growth. The company offers a range of financial services and investment opportunities tailored to meet the needs of its clients. With a dedicated team and a diverse portfolio, Schooner Capital aims to support businesses in achieving their financial goals.
Alexandria Venture Investments LLC Alexandria Venture Investments
Alexandria Venture Investments LLC Alexandria Venture Investments is a company that operates in the Venture Capital & Private Equity industry. It employs 1to4 people and has under500K of revenue. The company is headquartered in Hughesville, Maryland.
What's next for Remedy Plan?
The recent major enterprise-level funding infusion signifies a critical growth phase for Remedy Plan. This capital injection is expected to accelerate the advancement of their tunable NAMPT inhibitors through clinical trials and towards market readiness. The strategic investment will likely bolster research and development efforts, expand manufacturing capabilities, and support the company's commercialization strategy, reinforcing its trajectory in addressing significant unmet medical needs across oncology, metabolic disorders, and autoimmune diseases.
See full Remedy Plan company page
